Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients
<p>Abstract</p> <p>Background</p> <p>An altered expression of the activated leukocyte cell adhesion molecule (ALCAM) is associated with cancer progression in various cancer types. In some cancers ALCAM has a prognostic value or is predictive for the benefit of therapeut...
Main Authors: | Ihnen Maike, Kress Kerstin, Kersten Jan, Kilic Ergin, Choschzick Matthias, Zander Hilke, Müller Volkmar, Mahner Sven, Jänicke Fritz, Woelber Linn, Milde-Langosch Karin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/12/140 |
Similar Items
-
Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer
by: Mahner Sven, et al.
Published: (2011-01-01) -
Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases
by: M. Ihnen, et al.
Published: (2010-01-01) -
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
by: Jaenicke Fritz, et al.
Published: (2010-04-01) -
Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
by: Young Ju Jeong, et al.
Published: (2018-01-01) -
ALCAM (CD166) expression and serum levels in pancreatic cancer.
by: Michael Tachezy, et al.
Published: (2012-01-01)